|
|
||||||||
expression sensitizes primary human T cells toward apoptosis
University of Kaiserslautern, Institute of Cell Biology, Erwin-Schroedinger-Strasse, Germany
Correspondence: Andreas von Knethen, University of Kaiserslautern, Institute of Cell Biology, Erwin-Schroedinger-Strasse 13/420A, 67663 Kaiserslautern, Germany. E-mail: aknethen{at}rhrk.uni-kl.de
Phytohemagglutinin (PHA) elicited expression of peroxisome proliferator-activated receptor
(PPAR
) in primary human T cells via the PPAR
3 promoter, as shown by reverse transcription-polymerase chain reaction. Electrophoretic mobility shift assay demonstrated no correlation between PPAR
expression and its activation. However, addition of specific PPAR
agonists such as ciglitazone or 15-deoxy-
12,14-prostaglandin J2 (15d-PGJ2) for 1 h following PHA pretreatment provoked PPAR
activation verified by supershift analysis. Taking the proapoptotic properties of PPAR
into consideration, we analyzed induction of apoptosis in activated T cells in response to PPAR
agonists. Cells exposed to PPAR
agonists alone revealed minor cell death compared with controls, whereas treatment with 15d-PGJ2 or ciglitazone for 4 h subsequent to PHA stimulation significantly increased cell demise, which was attenuated by the pan-caspase inhibitor zVAD, pointing to apoptosis as the underlying mechanism. These data may be relevant for pathophysiological conditions accompanied with lymphopenia of T cells under conditions such as sepsis.
Key Words: inflammation lymphocyte cell death
This article has been cited by other articles:
![]() |
M. Soller, S. Drose, U. Brandt, B. Brune, and A. von Knethen Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells Mol. Pharmacol., June 1, 2007; 71(6): 1535 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zapata-Gonzalez, F. Rueda, J. Petriz, P. Domingo, F. Villarroya, A. de Madariaga, and J. C. Domingo 9-cis-Retinoic Acid (9cRA), a Retinoid X Receptor (RXR) Ligand, Exerts Immunosuppressive Effects on Dendritic Cells by RXR-Dependent Activation: Inhibition of Peroxisome Proliferator-Activated Receptor {gamma} Blocks Some of the 9cRA Activities, and Precludes Them to Mature Phenotype Development J. Immunol., May 15, 2007; 178(10): 6130 - 6139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Jo, C. Yang, Q. Miao, M. Marzec, M. A. Wasik, P. Lu, and Y. L. Wang Peroxisome Proliferator-Activated Receptor {gamma} Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities J. Immunol., September 15, 2006; 177(6): 3737 - 3745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Soller, A. Tautenhahn, B. Brune, K. Zacharowski, S. John, H. Link, and A. von Knethen Peroxisome proliferator-activated receptor {gamma} contributes to T lymphocyte apoptosis during sepsis J. Leukoc. Biol., January 1, 2006; 79(1): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cunard, Y. Eto, J. T. Muljadi, C. K. Glass, C. J. Kelly, and M. Ricote Repression of IFN-{gamma} Expression by Peroxisome Proliferator-Activated Receptor {gamma} J. Immunol., June 15, 2004; 172(12): 7530 - 7536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |